In recent years, medtech companies have been confronted with numerous, new government programs that require distinct compliance activities and reporting requirements. We’ve identified several that pose the serious challenges for medical device company executives and have assembled a series of leading experts to discuss compliance strategies that you can deploy. This program will offer registrants the latest and best information on Sunshine reporting; the Foreign Corrupt Practices Act; the Restriction of the Use of Certain Hazardous Substances (RoHS); and Good Clinical Practices. The afternoon session will focus on the root causes of several high profile FDA compliance cases.

Join us for a day of education, strategizing and networking with your regulatory affairs colleagues.